BBIO
BridgeBio Pharma Inc
66.60$
+0.0%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.1% | 95.8% | 90.0% | 91.4% | 87.8% | 88.1% | 87.4% | 78.4% | 80.5% | |
| 93.8% | 93.8% | 57.6% | 50.6% | 38.9% | 60.5% | 68.8% | 74.1% | 60.9% | |
| 93.8% | 93.8% | 86.4% | 86.3% | 82.6% | 75.7% | 79.6% | 74.1% | 62.8% | |
| – | – | 0.5% | – | 1.9% | 2.7% | 0.3% | 0.5% | 14.9% | |
| – | – | – | – | -6.8% | 6.1% | 3.0% | 0.0% | 2.9% | |
| 0.4% | 0.3% | 0.9% | 2.9% | 4.5% | 2.3% | – | – | – | |
| – | – | – | – | 4.4% | 4.6% | 4.8% | 2.6% | 3.0% | |
| 155.8% | 121.8% | 24.6% | 84.7% | 185.5% | 299.8% | 345.7% | 258.6% | 321.9% | |
| 8.7% | 7.0% | 9.6% | 13.6% | 13.3% | 19.5% | 26.3% | 16.8% | 30.8% | |
| – | – | 1.3% | 0.7% | 0.5% | 0.6% | 0.8% | 0.5% | 1.9% | |
| 1.9% | 2.9% | 1.4% | 1.3% | 1.2% | 1.9% | 2.0% | 1.0% | 3.9% | |
| – | 11.7% | 14.5% | 67.6% | 168.2% | 274.1% | 316.0% | 187.2% | 197.9% | |
| -59.2% | -35.3% | 64.7% | 8.2% | -85.9% | -201.4% | -247.9% | -159.7% | -221.9% | |
| -62.7% | -36.7% | -69.7% | -126.3% | -141.9% | -307.9% | -468.6% | -336.8% | -408.2% | |
| 94.2% | 19.9% | 16.6% | 16.8% | 14.3% | 23.7% | 29.8% | 20.2% | 21.1% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.